G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 95 filers reported holding G1 THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,338,000 | -52.4% | 721,925 | 0.0% | 0.12% | -53.6% |
| Q2 2020 | $17,514,000 | +120.1% | 721,925 | 0.0% | 0.25% | +61.0% |
| Q1 2020 | $7,956,000 | -58.3% | 721,925 | 0.0% | 0.15% | -49.2% |
| Q4 2019 | $19,080,000 | +16.0% | 721,925 | 0.0% | 0.30% | -1.0% |
| Q3 2019 | $16,445,000 | -20.2% | 721,925 | +7.4% | 0.31% | -13.1% |
| Q2 2019 | $20,601,000 | – | 671,925 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |